1
(Recasts, adds analyst comment, details and CFO comment) By Amina Niasse and Kunal Das Nov 9 (Reuters) – Hims & Hers Health said on Monday it will begin offering some unapproved peptide treatments in
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
